ViiV Healthcare (GSK) Deal History & Licensing Activity
ViiV Healthcare (GSK) is a life sciences. Over the past three years, ViiV Healthcare (GSK) has been involved in 5 licensing and acquisition transactions, with a primary focus on mRNA (2 deals).
Deals (12mo)
3
Active Trials
0
Top Modality
mRNA
Focus Area
Infectious Disease
ViiV Healthcare (GSK) Recent Deal Activity
Licensing, acquisition, and partnership transactions involving ViiV Healthcare (GSK) in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| mRNA vaccines for influenza | GSK | mRNA | Unknown | collaboration | Mar 2026 |
| JNJ-3989 | GSK | Other | Unknown | acquisition | Mar 2026 |
| RSV vaccine | GSK | Vaccines | Unknown | license | Jun 2025 |
ViiV Healthcare (GSK) Pipeline Focus
Therapeutic areas and modalities where ViiV Healthcare (GSK) is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
See How Your Asset Matches ViiV Healthcare (GSK)'s Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Infectious Disease assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Infectious Disease Deal Benchmarks
Market sizing, deal terms, and competitive landscape for infectious disease
mRNA Benchmarks
Upfront, milestone, and royalty benchmarks for mrna deals
Other Benchmarks
Upfront, milestone, and royalty benchmarks for other deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
About ViiV Healthcare (GSK) Licensing & Deal Activity
ViiV Healthcare (GSK) is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 5 deals over the past three years, ViiV Healthcare (GSK) ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for ViiV Healthcare (GSK) include Infectious Disease (8 deals and trials). In terms of modality, ViiV Healthcare (GSK) has shown particular interest in mrna, other, vaccines.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for ViiV Healthcare (GSK) and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against ViiV Healthcare (GSK)'s historical deal terms, or explore all company profiles to find the best partner match for your pipeline.